Research Excellence Award – Marko Radulovic
Marko Radulovic
Institute for Oncology and Radiology, Serbia
| Marko Radulovic |
| Affiliation |
Institute for Oncology and Radiology |
| Country |
Serbia |
| Scholar ID |
9GWuJvAAAAAJ |
| Documents |
91 |
| Citations |
2,347 |
| h-index |
25 |
| Subject Area |
Precision Medicine |
| Event |
Global Scientist Day Awards |
Marko Radulovic of the Institute for Oncology and Radiology, Serbia, has established a notable academic profile through extensive research activity, a substantial publication record, and significant citation impact within the field of Precision Medicine.[1] His body of work reflects continued engagement with translational and clinical research aimed at improving healthcare outcomes through evidence-based scientific inquiry.[2]
Abstract
This article presents an academic recognition profile of Marko Radulovic in consideration for the Research Excellence Award. The assessment is based on publicly available scholarly indicators, including publication productivity, citation performance, research influence, and disciplinary engagement in Precision Medicine. With 91 indexed scholarly documents, 2,347 citations, and an h-index of 25, his academic record demonstrates sustained scientific contribution and measurable impact within oncology-related and precision healthcare research domains.[1]
Keywords
Precision Medicine; Oncology Research; Clinical Translation; Cancer Studies; Research Excellence Award; Scientific Impact; Citation Analysis; Healthcare Innovation.
Introduction
Precision Medicine has emerged as a transformative area of modern healthcare by integrating molecular biology, clinical diagnostics, and patient-specific therapeutic strategies. Researchers operating within this field contribute to the development of individualized treatment approaches that improve clinical outcomes and optimize healthcare resources.[3] Marko Radulovic’s research activities align with these objectives through scholarly work that supports evidence-based advancement in cancer diagnosis, treatment optimization, and translational medicine.[2]
Research Profile
Marko Radulovic is affiliated with the Institute for Oncology and Radiology in Serbia, an institution recognized for its involvement in cancer research and clinical care. His scholarly profile demonstrates sustained participation in scientific publishing and multidisciplinary collaboration. The available bibliometric indicators suggest broad engagement with the international scientific community and a consistent record of knowledge dissemination.[1]
- Affiliation: Institute for Oncology and Radiology
- Country: Serbia
- Subject Area: Precision Medicine
- Documents: 91
- Citations: 2,347
- h-index: 25
Research Contributions
The scientific contributions associated with Marko Radulovic encompass areas relevant to oncology, personalized treatment strategies, clinical research methodologies, and translational medicine. His work contributes to the understanding of disease mechanisms and supports the integration of scientific discoveries into healthcare practice.[2]
- Advancement of precision-based clinical approaches.
- Contribution to oncology-related scientific literature.
- Support for evidence-driven patient management strategies.
- Participation in collaborative and multidisciplinary research initiatives.
- Dissemination of findings through peer-reviewed scholarly publications.
Publications
The research portfolio of Marko Radulovic includes 91 scholarly documents indexed through major academic databases. These publications collectively contribute to the advancement of knowledge in precision medicine and oncology-related disciplines.[1]
- Peer-reviewed research articles.
- Clinical and translational research studies.
- Collaborative multidisciplinary publications.
- Scientific communications addressing precision healthcare challenges.
Research Impact
Research impact may be assessed through scholarly visibility, citation performance, and influence on subsequent investigations. With 2,347 citations and an h-index of 25, Marko Radulovic’s work has demonstrated measurable recognition within the scientific community.[1] These indicators suggest that his publications have contributed to ongoing academic discourse and have informed related areas of biomedical research.[2]
Award Suitability
Based on available academic metrics and evidence of sustained scholarly activity, Marko Radulovic demonstrates characteristics commonly associated with candidates for research recognition programs. His publication record, citation influence, and contributions to precision medicine collectively support consideration for the Research Excellence Award. The combination of productivity, scientific impact, and disciplinary relevance reflects a mature and influential research profile.[1]
Conclusion
Marko Radulovic has developed a substantial academic record within the field of Precision Medicine through sustained research productivity and scholarly engagement. His documented achievements, publication output, and citation impact provide evidence of meaningful scientific contribution. These accomplishments align with the objectives of the Global Scientist Day Awards and support recognition through the Research Excellence Award.[1]
External Links
References
- Google Scholar. (n.d.). Marko Radulovic Citation Profile and Scholarly Metrics. Google Scholar. https://scholar.google.com/citations?user=9GWuJvAAAAAJ&hl=en&oi=ao
- Discriminative Pattern Mining for Breast Cancer Histopathology Image Classification via Fully Convolutional Autoencoder.
https://ieeexplore.ieee.org/abstract/document/8664469
- Pharmacology and Biology of Corticotropin-Releasing Factor (CRF) Receptors.
https://www.tandfonline.com/doi/abs/10.3109/10606820213678
- Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells. https://academic.oup.com/jimmunol/article-abstract/162/5/3013/8041238